Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
In these studies, no major adverse events have been reported
T bo Th1 kim sot kh nng min dch chng li k sinh trng ni bo (v d giun sn), trong khi cc t bo Th2 tng cng kh nng min dch chng li cc tc nhn gy bnh ngoi bo (v d vi khun, virus)
Access the form: This questionnaire gathers your essential health history, current medications, and weight loss goals to confirm your eligibility for GLP-1 treatment
Patients Who May Benefit Most Tirzepatide may be appropriate for patients who: Struggle to lose weight despite consistent effort Have prediabetes or Type 2 diabetes Experience PCOS-related weight gain Have elevated fasting insulin levels Carry excess abdominal or visceral fat Have a family history of diabetes Who May Not Be a Candidate Tirzepatide may not be appropriate for patients with: A history of medullary thyroid cancer Certain endocrine disorders Pregnancy or breastfeeding Severe gastrointestinal intolerance without supervision All eligibility decisions at Geneva are physician evaluated
Active skin infection, open lesions, dermatitis, complex wound history, pregnancy, lactation, immune compromise, copper metabolism disorders, and extensive concurrent dermatologic therapy may require added clinician evaluation
US$ 26.26
US$ 24.59
US$ 20.24
US$ 20.05
US$ 26.33
US$ 21.82
US$ 23.54
